Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-10 | New | $50,017,383 | $50,017,383 | Equity Only | 06b | SEC link |
| 2018-02-21 | New | $19,999,995 | $19,999,995 | Equity Only | 06b | SEC link |
| 2017-12-22 | New | $5,000,000 | $5,000,000 | Equity Only | 06b | SEC link |
| 2015-12-17 | New | $2,434,186 | $2,434,186 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Joseph Bonaccorso | Executive |
| Anthony Cavallo | Executive |
| Gavin Corcoran | Director |
| Matthew Davidson | Director, Executive, Promoter |
| Lawrence Eichenfield | Director |
| John Kirby | Executive |
| Paul B. Manning | Director |
| Diem Nguyen | Director |
| Glenn Oclassen | Director, Promoter |
| Mark Prygocki | Director |
| James C. Reebals | Executive, Promoter |
| Jayson Rieger | Director, Executive |
| Noah Rosenberg | Executive |
| Sean Stalfort | Director |
| Ted White | Executive |
| David Zawitz | Executive |